Study Design. This study represents a posthoc analysis of data collected from 2 control arms of a prospective, randomized study.
A nterior cervical discectomy and fusion (ACDF) has become a standard surgical treatment for patients with neck pain or upper extremity radicular symptoms failing nonoperative care, since described by Smith and Robinson over a half century ago. 1 Most surgeons feel that ACDF represents the surgical standard of care. In addition, clinical and radiographic outcomes following ACDF have been well established in the literature.
2,3 Fusion rates in single-level procedures have been reported to be approximately 90%. [4] [5] [6] Fusion rates with multilevel surgery have varied more, between 72% and 97.5%. 5, 7 Use of cadaveric allograft as a structural interbody graft has become a wellestablished alternative to autologous iliac crest graft. 5, 7, 8 Use of plating in conjunction with ACDF has been reported to significantly improve fusion rates. 2 One common concern associated with patients undergoing ACDF is of adjacent-level breakdown. Hilibrand et al 9 reported that the rate of symptomatic adjacent level degeneration in patients following ACDF is 2.9 % per year within the first 10 years following their index procedure. In addition, the authors predicted that 25.6% of patients having this surgery would have an onset of adjacent-level issues within 10 years of their initial procedure. More recently, Chung et al 10 reported clinical adjacent-level disease in 19 .2% of 177 patients with ACDF using plate fixation and at least a 10-year follow-up.
Another significant issue following ACDF is reoperation. Several studies reported reoperation rates ranging from 6.2% to 12.2% within 2 years. 10, 11 This was challenged by Singh et al, 12 reporting a reoperation rate of only 2.1% within 24 months.
Control arms of several cervical total disc replacement (TDR) Investigation Device Exemption (IDE) trials have followed single-level ACDF patients closely, reporting clinical outcomes similar to those in patients from the single-level TDR groups. [13] [14] [15] [16] [17] [18] [19] Unlike other Food and Drug Administration (FDA) IDE trials for cervical TDR, which were designed for single-level interventions, the Mobi-C device trial included investigational and control arms at both 1 and 2 levels. Other than the number of levels, the study selection criteria, surgical interventions, outcome assessments, participating surgeons, and independent radiographic analyses were identical. By studying ACDF control patients, this design provided a unique opportunity to compare results of 1-versus 2-level ACDF outcomes, with essentially all other variables being controlled. The purpose of this study was to perform such a comparison between the control arms of single-versus 2-level ACDF patients in the monitored environment of an U.S. Foods and Drug Administration (FDA)-regulated study.
MATERIALS AND METHODS
A total of 186 patients were randomized to ACDF, 81 in the single-level group and 105 in the 2-level group. Detailed inclusion and exclusion criteria for the IDE trials have previously been published. 20, 21 Enrollment required a diagnosis of degenerative disc disease with radiculopathy or myeloradiculopathy at 1 level or 2 contiguous levels from C3 to C7. Primary selection criteria were neck and/or arm pain with or without motor, sensory and/or reflex deficits, confirmative imaging study, age 18 to 69 years, no previous cervical fusion, and no prior surgery at the study level, BMI less than 40 kg/m 2 , not smoking more than a pack of cigarettes a day, Neck Disability Index (NDI) score greater than 30, unresponsive to at least 6 weeks of nonoperative care or progressive neurological problems, disc height of at least 3 mm, and bone mineral density scan T-score of not lower than À1.5 (osteoporosis).
The patients were enrolled in the FDA IDE trials investigating the Mobi-C Cervical Artificial Disc (LDR Medical, Troyes, France) compared with a control group, which consisted of patients receiving treatment with a standardized ACDF technique (Clinical trial registration number NCT00389597 on ClinicalTrials.gov). There were separate study arms comparing TDR with ACDF at 1 and 2 levels; each arm had a separate control group. In this study, clinical and radiographic results were compared between patients receiving a single-versus 2-level ACDF.
Both fusion groups received standardized operations consisting of an anterior cervical discectomy and decompression, followed by interbody grafting with corticocancellous allograft and anterior cervical plating. A standard Smith-Robinson approach was used to access the disc space, and typical discectomy, decompression of neural structures, and removal of osteophytes was performed. 
Postoperative Care
Each patient's postoperative care was determined by the treating physician with the plan to return him/her to typical activity as soon as possible. The postoperative protocol typically included pain medications, cervical collar, and physical therapy. Postoperative antibiotic prophylactic coverage was left to the treating physicians as per their typical protocol.
Outcomes Assessment
Patient evaluations were performed preoperatively and at 6 weeks, 3, 6, 12, 18, 24, 36, 48 , and 60 months postoperatively. The numbers of patients recruited and seen at each follow-up visit are provided in Figure 1 . Outcome measures used were the NDI, visual analog scales (VAS) assessing neck and arm pain, SF-12, patient satisfaction, revision surgery, and radiographic assessment including fusion and adjacent segment degeneration (ASD). Patient satisfaction was assessed using a survey asking patients whether they were very satisfied, somewhat satisfied, somewhat dissatisfied, or very dissatisfied with their treatment. Patients were also asked whether they would definitely, probably, probably not, or definitely not recommend the same treatment to a friend with the same symptoms and indications. Patient satisfaction rate was calculated by the number of patients very or somewhat satisfied over the total number of responses. Revision surgery was defined as subsequent surgery at the initial level(s), including removal of instrumentation or additional supplemental fixation. Neurological success was defined as the absence of significant neurological deficit (negative change in status) as evaluated by study investigators. These evaluations included sensory assessments with pinprick and light touch, motor assessments of muscle strength, and reflex assessments.
Radiographic Assessment
All radiographic analyses were performed according to a pre-specified radiograph protocol by Medical Metrics, Inc. (Houston, TX). Films were taken in the anteroposterior, lateral (neutral, flexion, extension), and side-bending projections. Quantitative assessments were performed with a validated proprietary software. 22 Evaluation of ASD, radiolucency, and bone bridging was performed by an independent qualified radiologist at the analysis facility. When evaluating ASD, each adjacent segment was assessed using the Kellgren-Lawrence scale of disc degeneration: none (0), minimal (1), definite (2), moderate (3), or severe (4). 23 Radiographic assessments were performed at baseline and postoperatively at 12, 24, 36, 48, and 60 months. An increase of at least 1 point compared with baseline was indicative of ASD. In patients undergoing 2-level ACDF, both levels had to be radiographically fused to be considered a success.
Statistical Analysis
Group mean scores were compared using the Student t test. Proportional data were compared using Chi-square with the exception of using the Fisher exact test to compare proportional data with small occurrences such as reoperation rates. The Wilcoxon signed-rank test was used to compare intragroup change from baseline. Statistical significance was accepted at a P value less than 0.05.
RESULTS

Patient Demographics
Gender, age, body mass index (BMI), and ability to drive were similar between the single-and 2-level groups (Table 1) . Five-year follow-up was achieved for 81.5% of the single-level group and 89.5% of the 2-level group.
Perioperative Data
Single-level ACDF was associated with statistically significantly less operative time and estimated blood loss compared with 2-level ( Table 2 ). Length of hospital stay was not significantly different.
Neck Disability Index
Preoperative NDI scores were similar in the 2 groups with values of 54.1 and 55.4 for 1-and 2-level respectively. Both groups demonstrated significant improvement in NDI scores postoperatively (P < 0.01; Figure 2 ), and by 1 year means that scores in both groups decreased more than 50% compared with baseline values. A statistically significant difference in NDI scores was found between the groups at 18, 36, 48, and 60-month follow-up (P < 0.05). 
VAS Pain Scores
Preoperative mean VAS neck pain scores were similar in the 2 groups. The mean neck pain scores improved significantly by 6-week follow-up and remained improved throughout 5-year follow-up in both groups (Figure 3) . The only statistically significant difference was at 12 months after surgery when the 1-level score was significantly less than the 2-level score (P < 0.05).
VAS arm pain was recorded separately for the right and left arms. Similar to neck pain scores, both groups demonstrated significant decreases in arm VAS scores to less than 50% of the preoperative score and these improvements were maintained during 5-year follow-up (Figure 4 ). There was no statistically significant difference in mean arm pain scores at any evaluation point when comparing 1-versus 2-level procedures.
Patient Satisfaction
At 60-month follow-up, the percentage of 1-level patients reporting being very satisfied with surgery was 83.9% versus 75.0% of 2-level patients (P > 0.20). In addition to rating satisfaction, patients were asked whether they would recommend the same treatment to a friend with the same surgical indications. At 60-month follow-up, 78.6% of the 1-level and 76.3% of the 2-level patients indicated that they would definitely recommend the same treatment they received (P > 0.70).
Quality of Life (SF-12)
Both groups had significant improvements in SF-12 baseline Physical Component Summary (PCS) and Mental Component Summary (MCS) scores by 6 months after surgery and improvements were maintained throughout follow-up. On the PCS scale, the single-level group had significantly greater scores at 12-month follow-up and points thereafter (P < 0.05; Figure 5 ). There were no statistically significant differences between groups when comparing MCS scores.
Neurological Status
At 5-year follow-up, neurological success rates, determined by the lack of neurological deterioration, in the 2 groups were similar with 93.8% in the 1-level group and 94.3% in the 2-level group.
Subsequent Surgical Intervention
Patients undergoing secondary surgery at the index level at 2-and 5-year follow-up in the 1-level group were 6.2% and 11.1% versus 11.4% and 16.2% in the 2-level group. These differences were not statistically significant (P > 0.10; Fisher's exact test). For the 1-level group, 5 patients underwent revision at the treated level for pseudoarthrosis, 1 patient for malpositioned screws, and 3 patients had their plate removed during an operation to treat ASD. For the 2-level group, 7 patients received an additional index level surgery for pseudoarthrosis, 1 patient for severe cervical instability, 1 patient for recurrent neck and arm pain, 1 patient for motor vehicle accident-related trauma, and 7 patients for instrumentation removal during an operation to treat ASD. The rates of reoperation at an adjacent segment were similar in the 2 groups with an occurrence of 11.1% of the 1-level group and 11.4% in the 2-level group at 5-year follow-up.
Return to Work
The median return to work time was 22 days in the 1-level group and 33 days in the 2-level group. The mean time to return to work in the single-level group was 36.8 AE 40.3 days versus 66.8 AE 113.7 days in the 2-level group. This represented a trend, as statistical significance was not reached (0.05 < P < 0.10).
Radiographic Outcomes
In the 2-level group, fusion had to be achieved at both levels for the patient to be considered a fusion success. The fusion rate was statistically significantly greater in the 1-level group at 6 and 12 months, with a trend at 24 months (Table 3) . Thereafter, fusion rates were not significantly different between groups. Fusion rates at 5 years were 93.3% in the 1-level group and 86.1% in the 2-level group.
Adjacent Segment Degeneration
ASD was assessed separately at the superior and inferior levels adjacent to the operated segment. At 5-year followup, ASD was noted in 54.7% of patients at the superior level and 44.7% at the inferior segment in the 1-level ACDF Ã Fusion failure rate statistically significantly less in the 1-level group (P < 0.05; Chi-square).
y Trend for lower fusion failure rate in 1-level group (0.05 <P < 0.10; Chi-square).
group and 70.8% and 55.0%, respectively, in the 2-level group. There was a trend for the difference to be significant at the superior level (0.05 < P < 0.10; Chi-square).
DISCUSSION
The design of the TDR trial included separate arms including patients undergoing surgery at 1 or 2 cervical levels, all with the same indications (with the exception of number of levels to be operated), all receiving the same fusion graft and anterior plates, and employing exactly the same outcome measures. Many patients in both groups were operated by the same surgeons participating in both trial arms. This design created a unique opportunity to compare outcomes of patients undergoing 1-versus 2-level ACDF with 5-year follow-up. The comparison of demographic characteristics found that the 2 groups were similar. The follow-up rates at 5 years were fairly high at 81.5% of the single-level group and 89.5% of the 2-level group. This is similar to previously reported IDE study rates at 5 years. 13 Only 2 patients were lost to follow-up between 48 and 60 months.
NDI scores, along with VAS neck and arms scores in both groups, were statistically significantly improved by 6 weeks after surgery compared with baseline. The early improvement in the single-level group maintained through 2-year follow-up was similar to other prospective studies reporting outcomes at specific time points. 14, 15, [17] [18] [19] 24 Through 5-year follow-up, both groups maintained statistically significant improvement and stable scores on the various outcome measures. These findings are similar to another study reporting these measures for single-level ACDF for this duration of follow-up. 13 One versus 2-level cervical TDR has been compared prospectively with 4-year follow-up. 25 As in the current study, statistically significant improvements were noted early that were maintained throughout follow-up in both groups. Unlike the current ACDF study, there was no statistically significant difference between 1-and 2-level TDR groups on any of the outcome measures, including the NDI, VAS pain scores, SF-12, and reoperations.
At 2-year follow-up, fusion rates were 89.3% in the 1-level group and 79.8% in the 2-level. These numbers are comparable to other studies evaluating single-level ACDF within this time frame. 15, 18, 26 In addition, our 2-level results at 24 months are comparable with those reported by Hacker et al 4 at 81.8%, and fall within results reported by Martin et al 5 and Joo et al, 27 respectively, at 72% and 92%. Singlelevel fusion rates were 93.3%, again similar to other singlelevel studies at 5 years. 13 In the 2-level ACDF patients, the 5-year fusion rate was 86.1%. The authors are unaware of any other studies in the literature that have reported 5-year fusion rates in this large group of 2-level ACDF patients.
There was a trend for a greater rate of ASD in the 2-level ACDF group. The rate at 5 years was higher than previously reported in the literature for single-level cases. This may be attributable, at least in part, to the sensitivity of the methods applied to determining ASD. In the current study, ASD was based only on radiographic changes as determined by radiologists at an independent image analysis center. The rate was much greater than one may expect on the basis of a classic study by Hilibrand et al, 9 who reported a rate of approximately 3% per year. In that study, ASD was defined as changes in the adjacent segment resulting in 2 or more consecutive visits for symptoms arising from the adjacent segment. This was much more restrictive than the radiographic criteria used in the current study. In general, there are many factors that may affect the rate of ASD, including the classification criteria for ASD, length of follow-up, operative technique, number of levels operated, patient population, methods of data capture, and possibly others. Bydon et al 28 reported that 12.2% of patients underwent revision surgery due to ASD symptoms at a mean of 46.4 months postoperative. In a study from Taiwan using data from a national surgery database, 5.6% of ACDF patients underwent additional surgery for ASD. 29 Perhaps one of the studies best demonstrating the impact of the criteria applied to classify a patient as having ASD comes from Chung et al 10 who evaluated a new ASD scoring system in a population of patients who were at least 40 years of age at the time of ACDF and were followed at least 10 years. They reported a 92.1% rate of radiographically identified ASD, 19.2% had clinically relevant symptoms, and 6.8% underwent additional surgery.
Secondary surgery in patients who underwent a singlelevel ACDF was 11.1%. This is very similar to the 11.3% in 1-level patients at the same follow-up duration.
13 For patients undergoing 2-level ACDF, secondary surgery was undertaken in 11.4% of patients at 2-year follow-up, which is in the range found by Veeravagu et al 11 for multilevel patients at 24 months in a large insurance company database analysis. At 5-year follow-up, the rate of secondary surgery in the 2-level group increased to 16.2%. The authors are unaware of any other studies in the literature that have reported 5-year secondary surgery rates in 2-level ACDF patients.
Both groups improved significantly from baseline preoperative status with respect to the recorded parameters. Patients undergoing single-level ACDF continually scored better in their results than those receiving 2-level ACDF throughout 5-year follow-up. This is the first study in the literature analyzing prospectively collected data on indications-matched cohorts of patients receiving either 1-or 2-level ACDF, with 5-year follow-up. Outcomes of patients undergoing single-level ACDF were better on some measures than for those undergoing 2-level fusion. However, patients in both groups had significantly improved scores on various outcome measures early after surgery and the improvements were maintained through 5-year follow-up. ACDF has been found to produce significant and durable improvements in outcomes measures, and validates the role of surgical intervention in patients with 1-or 2-level cervical radiculopathy that fail conservative treatment with persisting neurologic impairment.
Key Points
Comparing the control group data for the 1-and 2-level arms of a prospective total disc replacement study created a unique opportunity to compare ACDF outcomes in patients undergoing the procedure for the same indications (other than the number of levels with pathology), using the same surgical technique, and the same outcome measures. When analyzing outcomes in patients undergoing 1-or 2-level ACDF, statistically significant improvement was demonstrated as early as 6 weeks after surgery and maintained throughout 5-year follow-up in both groups. When comparing the outcomes of 1-versus 2-level ACDF, the outcomes were often similar, though the 1-level group demonstrated higher fusion rates at 6 and 12 months, greater improvement in NDI scores from 18 to 60 months, greater improvement in SF-12 PCS scores from 12 to 60 months, postoperatively.
